An expert review report released by the Food and Drug Administration (FDA) Monday raised doubts as to whether the vaccine developed by Taiwan-based United Biomedical Inc. (UBI) Asia offers sufficient protection against COVID-19 variants.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
U.S. dollar up in Taipei trading
11/15/2024 10:31 AM - Society
Taiwan headline news
11/15/2024 10:24 AM - Business
Taiwan shares open higher
11/15/2024 09:10 AM - Society
Flights, trains, ferry services in Taiwan affected by Typhoon Usagi
11/14/2024 11:52 PM - Sports
Taiwan edges Dominican Republic in second straight Premier12 group win
11/14/2024 11:39 PM